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Effects of calcium gluconate (GACa) and a new compound of calcium gluconate and
calcium lactate (Medical Super Ca; MSCa) on the growth of Bifidobacterium were in-
vestigated in vivo and in vitro.  In in vitro experiments, GACa and MSCa stimulated the
growth of B. bifidum in synthetic VLM medium.  However, these substances did not
stimulate, rather inhibited in part, the growth of B. bifidum in the complex medium
(GAM broth).  When 2.2 mg per mouse per day of GACa or MSCa was administered to
mice, and feces were assessed for anaerobic bacteria on VLM medium and for facultative
anaerobic bacteria on BTB-L agar, there was no difference among the 3 groups of mice
administered with or without GACa or MSCa.  Colony forming units (CFU) of B. bifidum
in feces of the mice drinking 2.2 mg of MSCa was 3.5 × 105 organisms per g of feces, a
value intermediate between those drinking 2.2 mg GACa (6.8 × 104) and controls (3.3 ×
106).  These results suggested that GACa and MSCa stimulated the growth of B. bifidum
in synthetic media, and that the effects of MSCa on the growth of bifidobacteria in vivo
and in vitro were intermediate between those of GACa and control.
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Many substances are well known as so-called
“foods for health”.  These include fructo-oligo-
saccharides (Gibson and Wang, 1994; Gibson et
al., 1995; Sghir et al., 1998; Sharp et al., 2001),
galacto-oligosaccharides (Sharp et al., 2001),
gluconic acid (Asano et al., 1994), lactic acid,
and lactosucrose (Ohkusa et al., 1995).  Fructo-
oligosaccharide stimulates the growth of Bifido-
bacterium (Gibson and Wang, 1994; Gibson et
al., 1995; Sghir et al., 1998; Sharp et al., 2001)
and administration of fructo-oligosaccharide
increases fecal bifidobacteria in healthy hu-
mans (Bouhnik et al., 1999).
Gluconic acid is widely distributed in natur-
al products such as rice, honey, wine, vinegar,
etc., and has been shown to stimulate the
growth of Bifidobacterium in the human intes-
tine and to have beneficial effects on the bacte-
Abbreviations:  BTB-L agar, bromthymol blue lactose agar; GACa, calcium gluconate; GAM, Gifu anaerobic
medium; MSCa, a compound of calcium gluconate and calcium lactate
rial flora in the human intestine (Asano et al.,
1994).  Calcium ions are necessary for the
strengthening of bones and teeth.  However, the
ordinary Japanese diet is lacking in calcium.
Calcium gluconate (GACa) is stable at room
temperature (Rubio and Moldenhauer, 1995)
and has been suggested to be useful as a health-
promoting food additive.
Calcium lactate dissolves readily and freely
in water and reduces intraoral demineralization
of enamel if ingested in the diet (Kashket and
Yaskell, 1992, 1997).
In the present study we investigated the
effects of a compound of calcium gluconate and
calcium lactate (MSCa) on the growth of Bifi-
dobacterium in vivo and in vitro.  MSCa dissolves
more rapidly and freely in water than GACa, and
is therefore expected to be a better food additive.
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Materials and Methods
Reagents and media
Calcium gluconate (GACa) was purchased from
Sigma (St. Louis, MO).  A compound of calcium
gluconate and calcium lactate (MSCa), which is
freely soluble in water, was obtained from
Nihon Medical (Tottori, Japan).  GAM for an-
aerobic bacteria and bromthymol blue lactose
agar (BTB-L agar) were obtained commercially
from Nissui Seiyaku (Tokyo, Japan).  VLM me-
dium was used as a nonselective medium for an-
aerobic bacteria (Tanaka et al., 1997).  Resazurin
was purchased from Wako Pure Chemicals
(Osaka, Japan) and cysteine-HCl was obtained
from Sigma.  MPN medium was used as a selec-
tive medium for Bifidobacterium (Tanaka and
Mutai, 1980).  Biotin, riboflavin, adenine, gua-
nine, uracil and Tween 80 were purchased from
Wako Pure Chemicals.  Xanthine and pyruvic
acid were from Sigma, and pantothenic acid and
nalidixic acid were from Nakalai Chemicals
(Kyoto, Japan).  GACa and MSCa were dis-
solved in GAM medium and VLM medium,
and autoclaved before use.  The ingredients in
100 mL of anaerobic dilution fluid were as fol-
lows:  3.75 mL of 0.78% K2HPO4, 3.75 mL of a
salt solution consisting of 0.47% KH2PO4, 1.18%
NaCl, 1.2% (NH4)2SO4, 0.12% of CaCl2 and
0.25% MgSO4  • H2O, 0.1 mL of 0.1% resazurin,
0.1 mL of 5% L-cysteine  • HCl, 0.2 mL of 25% L-
ascorbic acid, 5 mL of 8% Na2CO3 and distilled
water.
Bacterial strain
Bifidobacterium bifidum strain Hino used in
this experiment was kindly supplied by Dr. M.
Ueda, Tottori University College of Medical Care
Technology and stored in GAM broth at –30˚C.
An aliquot of the stock solution of Bifido-
bacterium was added to fresh GAM broth in a
test tube with a tight-fitting cap, anaerobically
incubated at 37˚C overnight and used for the ex-
periments.
Growth of Bifidobacterium in culture
media
Aliquots of 10 µL of the culture were added
under a stream of hydrogen peroxide gas to test
tubes with GAM broth containing GACa at a
final concentration of 1% (GACa1) or 2%
(GACa2) or MSCa at a final concentration of
1% (MSCa1) or 2% (MSCa2).  These test tubes
were closed tightly with a cap, and anaerobi-
cally incubated at 37˚C for 16 h.  After serial
dilution with anaerobic dilution fluid under a
stream of hydrogen peroxide gas, aliquots of
100 µL of the suspension were put onto VLM
agar plates, incubated in an anaerobic jar at
37˚C for about 1 week and the viable organisms
were enumerated by the colony counting meth-
od.  Similar experiments were performed using
VLM medium containing GACa1 or GACa2
and MSCa1 or MSCa2, and put onto VLM agar
plates for colony counting.
Isolation of bacteria from feces of mice
GACa and MSCa were suspended in water at a
concentration of 0.75% and sterilized by auto-
claving.  Six-week-old BALB/c mice (4 to 6;
female) were bred in cages, and were given free
access to solid food (CE-2; Clea Japan, Tokyo)
and water containing GACa or MSCa.  The
doses of GACa and MSCa consumed by mouse
per day were calculated from the decrease in
amount of water in the bottle.  In another ex-
periment, granules of 20 mg of MSCa were ad-
ministered directly into the animal’s mouth
with a small spoon.
After at least 2 weeks under these condi-
tions, the feces were collected directly in a vinyl
bag with 1 mL of anaerobic dilution fluid.  Imme-
diately after closing the vinyl bag and weighing,
the suspension of feces was serially diluted with
anaerobic dilution fluid under a stream of car-
bon dioxide gas.  Aliquots of 100 µL of each sus-
pension were put onto VLM agar plates, MPN
agar plates and BTB-L agar plates, and incubat-
ed in an anaerobic jar at 37˚C for about 2 weeks,
followed by colony counting.
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Statistical analysis
Student’s t-test was used for statistical analysis
to test for differences between the groups.
Results
Growth of B. bifidum in GAM broth and
VLM medium
B. bifidum grew in GAM broth and reached 2.1
× 108 cells per mL after 16 h in culture at 37˚C.
The numbers of bacteria in GAM broth contain-
ing GACa1 and GACa2 were 60% and 46%, re-
spectively, of those in control GAM broth with
no additive.  More bacteria grew in GAM broth
containing MSCa1 or MSCa2 than in that con-
taining GACa1 or GACa2 (Fig. 1).  Interesting-
ly, the numbers of bacteria grown in all GAM
broth containing GACa or MSCa were less than
that in control GAM broth.  Thus, GACa and
MSCa did not have any positive effect on the
growth of Bifidobacterium.  The numbers of vi-
able organisms in GAM broth containing GACa
and MSCa decreased in a dose-dependent man-
ner.
Fig. 2.  Growth of B. bifidum in VLM medium supplemented with MSCa and
GACa.  The growth of B. bifidum in VLM medium was approximately 2.0 × 107
organisms per mL of medium.  B. bifidum growth in VLM medium containing
MSCa and GACa is shown as the relative ratio of the number of viable organisms
to that in controls.  Symbols are the same as in Fig. 1.
Fig. 1.  Growth of Bifidobacterium bifidum in GAM
broth supplemented with MSCa and GACa.  The
growth of B. bifidum in GAM broth was approxi-
mately 2.1 × 108 organisms per mL of medium, and
this is shown as 100% viable organisms.  Other data
are shown as percentages relative to this value.
MSCa1 ( ) and MSCa2 ( ) indicate GAM broth
containing MSCa at final concentrations of 1% and
2%, respectively.  GACa1 ( ) and GACa2 ( ) indi-
cate GAM broth containing GACa at final concen-
trations of 1% and 2%, respectively.  (–) indicates
GAM broth with no additive ( ).  Typical data from
1 of 3 separate experiments are shown.
B. bifidum grew in VLM medium and reach-
ed 2.0 × 107 organisms per mL.  In contrast to
GAM broth, B. bifidum grew well in VLM me-
dium containing GACa1 and GACa2, and
reached 2.6 × 108 and 4.5 × 108 organisms per
mL, respectively, which were 13-fold and 23-
fold, respectively, greater than the control (Fig.
2).  The bacteria also grew in VLM medium
containing MSCa1 and MSCa2, as shown in
Fig. 2.  The viable cell number in VLM medium
containing GACa and MSCa increased in a
dose-dependent manner.
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Discussion
Bifidobacterium is thought to exert health-
promoting effects for humans (Sghir et al., 1998).
Its effects include inhibition of abnormal fer-
mentation, production of vitamin B complexes,
acceleration of peristaltic movement, stimula-
tion of the immune system and inhibition of the
production of carcinogenic substances.  The in
vitro experiments indicated that the growth of
Bifidobacterium was stimulated, while that of
Clostridium perfringens was not stimulated,
rather inhibited, by gluconic acid or oligofruc-
tose (Asano et al., 1994; Catala et al., 1999).
The growth of Bifidobacterium was inhibit-
ed by adding GACa and MSCa to GAM broth
and stimulated by adding GACa and MSCa to
Isolation of bacteria from feces of mice
The number of bacteria isolated on VLM agar
plates from the feces of mice fed approximately
2.2 mg of GACa or MSCa per mouse per day
was about 1.3 × 109 organisms per g of feces
(Fig. 3).  There was no difference among the 3
groups of mice examined.  However, feces of
mice drinking 2.2 mg of GACa yielded only 6.8
× 104 organisms per g of feces on MPN agar
plates.  That value was significantly less than
that (3.3 × 106 organisms) in the control group.
The number of viable bacteria in feces of mice
drinking 2.2 mg of MSCa, was 3.5 × 105
organisms per g of feces, a value intermediate
between the group drinking 2.2 mg of GACa
and controls.
To search for facultative anaerobic bacteria
and anaerobic bacteria in feces, we put the sam-
ples from feces onto BTB-L agar plates and
VLM agar plates.  BALB/c mice were orally ad-
ministered 20 mg of MSCa every day and their
feces were collected for isolation of bacteria.
As shown in Fig. 4, there were no differences in
the number of viable organisms associated with
use of BTB-L agar plates and VLM agar plates.
Fig. 3.  Isolation of anaerobic bacteria from feces of
mice given water containing MSCa or GACa.  Num-
bers of colony forming units (CFU) of viable organ-
isms in feces were assessed on VLM agar plates ( )
and MPN agar plates ( ).  Each column shows an
average ± SD of 3 to 5 experiments.  **P < 0.05
relative to control.
Fig. 4.  Numbers of colony forming units (CFU) of mouse intestinal bacteria.
Bacterial suspensions were prepared from the feces of mice, fed 20 mg of MSCa
every day.  A fixed amount of the suspension was serially diluted with anaerobic
dilution fluid, and viable organisms were enumerated on BTB-lactose agar plates
( ) and VLM agar plates ( ).  (–) indicates CFU from feces of mice without
MSCa.  Each column shows the average ± SD of 5 to 8 separate experiments.
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VLM medium (Figs. 1 and 2).  As GAM broth
contains peptone, soy peptone, proteose peptone,
decomposed serum, yeast extract and liver ex-
tract, it is a nutrient-rich medium.  Thus, GAM
broth may contain sufficient amounts of glucon-
ic acid and calcium ions for bacterial growth.
However, a large excess of calcium ions might
inhibit the growth of Bifidobacterium.  VLM
medium is less nutrient-rich, and therefore addi-
tion of gluconic acid and calcium ions to this
medium might improve the growth of Bifido-
bacterium.
There are large numbers of anaerobic bacte-
ria and facultative anaerobic bacteria in the
mouse intestine.  The total numbers of these an-
aerobic bacteria and facultative aerobic bacteria
in the feces of the mice drinking water supple-
mented with 0.75% MSCa were similar to those
in the feces of controls (Fig. 4).  However, there
were fewer Bifidobacterium organisms in
mouse feces as compared with the human feces
described by Asano et al. (1994).  When 2.2 mg
of GACa was given to mice in the drinking
water, the number of Bifidobacterium was sig-
nificantly decreased.  Administration of 2.2 mg
of MSCa reduced the number of Bifidobacte-
rium but this effect was not significant.  As the
solid food given to mice is nutrient-rich and
may contain sufficient amounts of substances
similar to gluconic acid and calcium ions, it
might be unnecessary to add MSCa to the feed.
The excessive administration of calcium ions
might inhibit the growth of Bifidobacterium in
the mouse intestine.
In these experiments, we found that the
growth of B. bifidum in GAM broth supple-
mented with MSCa was inhibited, but not to a
greater extent than that in GAM broth with
GACa.  Addition of MSCa to VLM medium
stimulated the growth of B. bifidum.  Further-
more, by administration of MSCa in the drink-
ing water, the number of Bifidobacterium orga-
nisms isolated from the feces of the mice was
reduced relative to the controls, although this
effect was not significant.  For application of
MSCa for human use, further studies on the
isolation of Bifidobacterium from the feces of
subjects taking MSCa are required.
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